Research - Los Angeles, California, United States
Founded by early pioneers of T cell receptor (TCR) therapy, T-Cure strives to find cure of human cancer using its cutting edge TCR-T technologies. Using its proprietary iSORT TCR discovery platform, T-Cure expects to rapidly grow its pipeline of therapy candidates. The Company believes its TCR hold great promise in treating patients unaddressed by current modalities.
Gmail
Nginx
WordPress.org
Blue Host
Google Apps